Myriad Genetics, Inc. (MYGN)
5.92
-0.37
(-5.88%)
USD |
NASDAQ |
Nov 06, 16:00
5.89
-0.03
(-0.51%)
After-Hours: 20:00
Myriad Genetics Total Long Term Debt (Quarterly) : 201.60M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 201.60M |
| June 30, 2026 | 203.20M |
| March 31, 2026 | 204.40M |
| December 31, 2025 | 202.90M |
| September 30, 2025 | 204.40M |
| June 30, 2025 | 86.20M |
| March 31, 2025 | 146.70M |
| December 31, 2024 | 127.50M |
| September 30, 2024 | 129.60M |
| June 30, 2024 | 130.00M |
| March 31, 2024 | 133.00M |
| December 31, 2023 | 135.90M |
| September 30, 2023 | 183.60M |
| June 30, 2023 | 186.80M |
| March 31, 2023 | 146.50M |
| December 31, 2022 | 130.90M |
| September 30, 2022 | 123.30M |
| June 30, 2022 | 87.40M |
| March 31, 2022 | 76.50M |
| December 31, 2021 | 79.30M |
| September 30, 2021 | 80.70M |
| June 30, 2021 | 188.00M |
| March 31, 2021 | 203.40M |
| June 30, 2020 | 281.30M |
| March 31, 2020 | 281.10M |
| Date | Value |
|---|---|
| December 31, 2019 | 283.80M |
| September 30, 2019 | 287.60M |
| June 30, 2019 | 233.50M |
| March 31, 2019 | 263.40M |
| December 31, 2018 | 273.30M |
| September 30, 2018 | 258.00M |
| June 30, 2018 | 9.30M |
| March 31, 2018 | 69.30M |
| December 31, 2017 | 43.20M |
| September 30, 2017 | 74.20M |
| June 30, 2017 | 99.10M |
| March 31, 2017 | 167.10M |
| December 31, 2016 | 204.00M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 6.593B |
| Sera Prognostics, Inc. | 3.017M |
| BioRestorative Therapies, Inc. | 0.00 |
| CareDx, Inc. | 20.32M |
| Natera, Inc. | 142.62M |